Kisia L, Cheng Q, Raballah E, Munde E, McMahon B, Hengartner N
Trop Med Health. 2022; 50(1):41.
PMID: 35752805
PMC: 9233820.
DOI: 10.1186/s41182-022-00432-5.
Skorokhod O, Barrera V, Mandili G, Costanza F, Valente E, Ulliers D
Antioxidants (Basel). 2021; 10(8).
PMID: 34439507
PMC: 8389202.
DOI: 10.3390/antiox10081259.
Chin S, Chorro L, Chan J, Lauvau G
Infect Immun. 2019; 87(12).
PMID: 31591168
PMC: 6867857.
DOI: 10.1128/IAI.00482-19.
Natama H, Moncunill G, Rovira-Vallbona E, Sanz H, Sorgho H, Aguilar R
BMC Med. 2018; 16(1):198.
PMID: 30384846
PMC: 6214168.
DOI: 10.1186/s12916-018-1187-3.
Ng S, Souza-Fonseca-Guimaraes F, De Labastida Rivera F, Amante F, Kumar R, Gao Y
Clin Transl Immunology. 2018; 7(1):e1003.
PMID: 29484181
PMC: 5822408.
DOI: 10.1002/cti2.1003.
Plant Hormone Salicylic Acid Produced by a Malaria Parasite Controls Host Immunity and Cerebral Malaria Outcome.
Matsubara R, Aonuma H, Kojima M, Tahara M, Andrabi S, Sakakibara H
PLoS One. 2015; 10(10):e0140559.
PMID: 26466097
PMC: 4605785.
DOI: 10.1371/journal.pone.0140559.
Potential role of Plasmodium falciparum-derived ammonia in the pathogenesis of cerebral malaria.
Kimoloi S, Rashid K
Front Neurosci. 2015; 9:234.
PMID: 26190968
PMC: 4490226.
DOI: 10.3389/fnins.2015.00234.
Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
Guiguemde W, Hunt N, Guo J, Marciano A, Haynes R, Clark J
Antimicrob Agents Chemother. 2014; 58(8):4745-54.
PMID: 24913162
PMC: 4135990.
DOI: 10.1128/AAC.01553-13.
The contribution of natural killer complex loci to the development of experimental cerebral malaria.
Hansen D, Ryg-Cornejo V, Ioannidis L, Chiu C, Ly A, Nie C
PLoS One. 2014; 9(4):e93268.
PMID: 24691125
PMC: 3972225.
DOI: 10.1371/journal.pone.0093268.
Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.
Kim H, Erdman L, Lu Z, Serghides L, Zhong K, Dhabangi A
Infect Immun. 2013; 82(1):371-9.
PMID: 24191300
PMC: 3911851.
DOI: 10.1128/IAI.01246-13.
The neuropathology of fatal cerebral malaria in malawian children.
Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten R, Milner D
Am J Pathol. 2011; 178(5):2146-58.
PMID: 21514429
PMC: 3081150.
DOI: 10.1016/j.ajpath.2011.01.016.
Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.
Robinson L, DOmbrain M, Stanisic D, Taraika J, Bernard N, Richards J
Infect Immun. 2009; 77(7):3033-43.
PMID: 19380468
PMC: 2708537.
DOI: 10.1128/IAI.00211-09.
Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria.
Ropert C, Franklin B, Gazzinelli R
Semin Immunopathol. 2007; 30(1):41-51.
PMID: 18071705
DOI: 10.1007/s00281-007-0103-2.
The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA.
Hansen D, Evans K, DOmbrain M, Bernard N, Sexton A, Buckingham L
Infect Immun. 2005; 73(4):2288-97.
PMID: 15784573
PMC: 1087422.
DOI: 10.1128/IAI.73.4.2288-2297.2005.
Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.
Riopel J, Tam M, Mohan K, Marino M, Stevenson M
Infect Immun. 2000; 69(1):129-36.
PMID: 11119498
PMC: 97864.
DOI: 10.1128/IAI.69.1.129-136.2001.
Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack.
Chougnet C, Tallet S, Ringwald P, Deloron P
Clin Exp Immunol. 1992; 90(3):405-8.
PMID: 1458676
PMC: 1554569.
DOI: 10.1111/j.1365-2249.1992.tb05859.x.